Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Senke Pharmaceutical, officially known as Hunan Senke Pharmaceutical Co., Ltd., is a Chinese pharmaceutical manufacturer established in 2004 and headquartered in Loudi, Hunan. The company specializes in the large-scale production of quinolone antibiotics, offering a comprehensive portfolio of active pharmaceutical ingredients (APIs) and finished dosage forms. Its core products include widely used anti-infectives such as ciprofloxacin, levofloxacin, and moxifloxacin, catering to both the human healthcare and veterinary sectors. Senke Pharmaceutical operates from modern, GMP-certified facilities equipped for advanced chemical synthesis and stringent quality control. The company is a significant participant in the global pharmaceutical supply chain, exporting its products to various international markets. Currently, it maintains a focus on process optimization and expanding its manufacturing capabilities for generic antimicrobial therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Senke Pharmaceutical.